Related Experiment Video
Updated: May 18, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Chromosomal aberrations and fusion genes in myeloid malignancies
Valentina Gianfelici1, Idoya Lahortiga, Jan Cools
1Center for Human Genetics, KU Leuven, Leuven, Belgium. valentina.gianfelici@cme.vib-kuleuven.be
Abstract:
Since the discovery of the BCR-ABL1 fusion gene in chronic myeloid leukemia, many more fusion genes resulting from chromosomal rearrangements have been identified and characterized. The study of these fusion genes has been extremely important for our understanding of the role of chromosomal rearrangements in leukemogenesis and in oncology in general. In chronic myeloid leukemia, or related myeloproliferative malignancies caused by the expression of oncogenic fusion kinases, tyrosine kinase inhibitors are now successfully used to treat these diseases. In acute myeloid leukemias, the presence of chromosomal rearrangements, oncogenic fusion genes and point mutations in key oncogenic drivers has important prognostic value and determines the choice of therapy. In this review, the authors provide an overview of the important fusion genes present in various myeloid malignancies and their importance for clinical practice.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic cells are...
Differentiation of Common Myeloid Progenitor Cells
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

